Clash of the Titans: Conflicts in the Regulation of Medical Devices by the FDA and PTO

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Lazebnik, Ron	en_US
dc.date.accessioned	2012-12-07T15:13:35Z
dc.date.issued	2005	en_US
dc.identifier.citation	Clash of the Titans: Conflicts in the Regulation of Medical Devices by the FDA and PTO (2005 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:10015267
dc.description.abstract	This paper discusses two of the conflicts created by the fact that both the Food and Drug Administration and the Patent and Trademark Office regulate medical devices and drugs. A brief description of the two agencies is made to give a sense of their goals and of their resources involved. The conflicts discussed are the effect each agency has on the monopolistic power a company may have in the market, and the problem arising from the term â€&oelig;substantial equivalenceâ€ being used by the agencies for very contrary goals. With each conflict, the method to resolve the problem is discussed, be it by acts of Congress, the Courts, or the industry itself.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	FDA	en
dc.subject	PTO	en
dc.title	Clash of the Titans: Conflicts in the Regulation of Medical Devices by the FDA and PTO	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-12-07T15:13:35Z